Global Oncology Biosimilars Market Research Report 2016
- SPI1022750
- 131 Pages
- February 2017
- Pharmaceuticals
Cancer represents a massive burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of several cancer therapeutics has allowed the entry of biosimilars, which are being incorporated into oncology treatment practices. Biosimilars are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes. The market offers huge growth opportunities for vendors because of the growing incidence of cancer. The clinical pipeline for cancer biosimilars is vast, featuring candidates in different stages of development. Around 30% of all the biosimilars that are awaiting the US FDA’s approval are monoclonal antibodies, including biosimilars of Avastin, MabThera, and Herceptin.
Factors like the arrival of new biosimilars to drive market growth during the forecast period. Unlike generic drugs, which have APIs that are identical to original drugs, biosimilars are similar to their originator biologic compounds. Biosimilars developed by different manufacturers differ from the original product as well as from each other. Since they are less expensive than biologics, patients will be able to afford and access biosimilars more easily than biologics. Rise in number of patent expiries, increase in prevalence of cancer, growing aging population, promising drug pipeline, need for cost-effective treatment, favorable government regulations are some of the key drivers promoting the growth of oncology biosimilars market.
The Global Oncology Biosimilars Market Research Report 2016 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Oncology Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
Global Oncology Biosimilars Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India
The Major players reported in the market include:
Biocon
Amgen
Celltrion
Hospira
Biogen
Mylan
Pfizer
Dr. Reddy's Laboratories
Roche
GlaxoSmithKline (GSK)
Merck
Sanofi and Sandoz.
...
Global Oncology Biosimilars Market: Product Segment Analysis
Type I
Type II
Type III
Global Oncology Biosimilars Market: Application Segment Analysis
Application I
Application II
Application III
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
Chapter 1 Oncology Biosimilars Market Overview
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Market Segmentation by Type
1.2.1 Global Production Market Share of Oncology Biosimilars by Type in 2015
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Oncology Biosimilars Market Segmentation by Application
1.3.1 Oncology Biosimilars Consumption Market Share by Application in 2015
1.3.2 Application I
1.3.3 Application II
1.3.4 Application III
1.4 Oncology Biosimilars Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Oncology Biosimilars (2011-2021)
Chapter 2 Global Economic Impact on Oncology Biosimilars Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
2.3 Effects to Oncology Biosimilars Industry
Chapter 3 Global Oncology Biosimilars Market Competition by Manufacturers
3.1 Global Oncology Biosimilars Production and Share by Manufacturers (2015 and 2016)
3.2 Global Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Oncology Biosimilars Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
3.5 Oncology Biosimilars Market Competitive Situation and Trends
3.5.1 Oncology Biosimilars Market Concentration Rate
3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Oncology Biosimilars Production, Revenue (Value) by Region (2011-2016)
4.1 Global Oncology Biosimilars Production by Region (2011-2016)
4.2 Global Oncology Biosimilars Production Market Share by Region (2011-2016)
4.3 Global Oncology Biosimilars Revenue (Value) and Market Share by Region (2011-2016)
4.4 Global Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.5 North America Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.6 Europe Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.7 China Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.8 Japan Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.9 Southeast Asia Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
4.10 India Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Chapter 5 Global Oncology Biosimilars Supply (Production), Consumption, Export, Import by Regions (2011-2016)
5.1 Global Oncology Biosimilars Consumption by Regions (2011-2016)
5.2 North America Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.3 Europe Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.4 China Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.5 Japan Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.6 Southeast Asia Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
5.7 India Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
Chapter 6 Global Oncology Biosimilars Production, Revenue (Value), Price Trend by Type
6.1 Global Oncology Biosimilars Production and Market Share by Type (2011-2016)
6.2 Global Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
6.3 Global Oncology Biosimilars Price by Type (2011-2016)
6.4 Global Oncology Biosimilars Production Growth by Type (2011-2016)
Chapter 7 Global Oncology Biosimilars Market Analysis by Application
7.1 Global Oncology Biosimilars Consumption and Market Share by Application (2011-2016)
7.2 Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Global Oncology Biosimilars Manufacturers Analysis
8.1 Biocon
8.1.1 Company Basic Information, Manufacturing Base and Competitors
8.1.2 Product Type, Application and Specification
8.1.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.1.4 Business Overview
8.2 Amgen
8.2.1 Company Basic Information, Manufacturing Base and Competitors
8.2.2 Product Type, Application and Specification
8.2.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.2.4 Business Overview
8.3 Celltrion
8.3.1 Company Basic Information, Manufacturing Base and Competitors
8.3.2 Product Type, Application and Specification
8.3.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.3.4 Business Overview
8.4 Hospira
8.4.1 Company Basic Information, Manufacturing Base and Competitors
8.4.2 Product Type, Application and Specification
8.4.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.4.4 Business Overview
8.5 Biogen
8.5.1 Company Basic Information, Manufacturing Base and Competitors
8.5.2 Product Type, Application and Specification
8.5.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.5.4 Business Overview
8.6 Mylan
8.6.1 Company Basic Information, Manufacturing Base and Competitors
8.6.2 Product Type, Application and Specification
8.6.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.6.4 Business Overview
8.7 Pfizer
8.7.1 Company Basic Information, Manufacturing Base and Competitors
8.7.2 Product Type, Application and Specification
8.7.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.7.4 Business Overview
8.8 Dr. Reddy'sLaboratories
8.8.1 Company Basic Information, Manufacturing Base and Competitors
8.8.2 Product Type, Application and Specification
8.8.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.8.4 Business Overview
8.9 Roche
8.9.1 Company Basic Information, Manufacturing Base and Competitors
8.9.2 Product Type, Application and Specification
8.9.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.9.4 Business Overview
8.10 GlaxoSmithKline(GSK)
8.10.1 Company Basic Information, Manufacturing Base and Competitors
8.10.2 Product Type, Application and Specification
8.10.3 Sales, Revenue, Price and Gross Margin (2011-2016)
8.10.4 Business Overview
8.11 Merck
8.12 Sanofiand
8.13 Sandoz.
Chapter 9 Oncology Biosimilars Manufacturing Cost Analysis
9.1 Oncology Biosimilars Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Price Trend of Key Raw Materials
9.1.3 Key Suppliers of Raw Materials
9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.2.1 Raw Materials
9.2.2 Labor Cost
9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Oncology Biosimilars
Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers
10.1 Oncology Biosimilars Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
10.4 Downstream Buyers
Chapter 11 Analysis of Investment Strategy
11.1 Industry Development Characters
11.1.1 Periodicity of the industry
11.1.2 Regional traits of the industry
11.1.3 Upstream and downstream of Oncology Biosimilars industry
11.1.4 Operational mode of the industry
11.2 Analysis of Investment Situation of Oncology Biosimilars Industry
11.2.1 Development Pattern
11.2.2 Entry Barrier
11.2.3 Industrial SWOT Analysis
11.2.4 Analysis of Industrial Five Forces Mode
11.3 Analysis of Development Trend
Chapter 12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
Chapter 13 Market Effect Factors Alysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
Chapter 14 Global Oncology Biosimilars Market Forecast (2016-2021)
14.1 Global Oncology Biosimilars Production, Revenue Forecast (2016-2021)
14.2 Global Oncology Biosimilars Production, Consumption Forecast by Regions (2016-2021)
14.3 Global Oncology Biosimilars Production Forecast by Type (2016-2021)
14.4 Global Oncology Biosimilars Consumption Forecast by Application (2016-2021)
14.5 Oncology Biosimilars Price Forecast (2016-2021)
Chapter 15 Research Findings and Conclusion
Chapter 16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Table Product Overview and Scope of Oncology Biosimilars
Table Major Manufacturers of Type I
Table Major Manufacturers of Type II
Table Major Manufacturers of Type III
Table Oncology Biosimilars Consumption Market Share by Application in 2015
Table Global Oncology Biosimilars Capacity of Key Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Capacity Market Share by Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Production of Key Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Production Share by Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Global Oncology Biosimilars Revenue Share by Manufacturers
Table Global Market Oncology Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Table Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology Biosimilars Product Type
Table Global Oncology Biosimilars Capacity by Regions (2011-2016)
Table Global Oncology Biosimilars Production by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue Market Share by Regions (2011-2016)
Table 2015 Global Oncology Biosimilars Revenue Market Share by Regions
Table Global Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table India Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Oncology Biosimilars Consumption Market by Regions (2011-2016)
Table Global Oncology Biosimilars Consumption Market Share by Regions (2011-2016)
Table North America Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Europe Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table China Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Japan Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table India Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Global Oncology Biosimilars Production by Type (2011-2016)
Table Global Oncology Biosimilars Production Share by Type (2011-2016)
Table Global Oncology Biosimilars Revenue by Type (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Type (2011-2016)
Table Global Oncology Biosimilars Price by Type (2011-2016)
Table Global Oncology Biosimilars Consumption by Application (2011-2016)
Table Global Oncology Biosimilars Consumption Market Share by Application (2011-2016)
Table Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)
Table Biocon Basic Information List
Table Biocon Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Oncology Biosimilars Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Oncology Biosimilars Global Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Oncology Biosimilars Global Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Oncology Biosimilars Global Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Oncology Biosimilars Global Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mylan Oncology Biosimilars Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Oncology Biosimilars Global Market Share (2011-2016)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Oncology Biosimilars Global Market Share (2011-2016)
Table GlaxoSmithKline (GSK) Basic Information List
Table GlaxoSmithKline (GSK) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline (GSK) Oncology Biosimilars Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Oncology Biosimilars Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Oncology Biosimilars Global Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz Oncology Biosimilars Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Table Key Suppliers of Raw Materials
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Table Four basic brand strategies
Table Industrial SWOT Analysis
Table Global Oncology Biosimilars Production Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Consumption Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Production Forecast by Type (2016-2021)
Table Global Oncology Biosimilars Consumption Forecast by Application (2016-2021)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
